Filing metadata

Accession number
0001415889-23-005819
Form type
Form 3
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Apr 03, 2023
Reporting period
Mar 30, 2023
Description
Initial ownership

Explore SEC Filings Hub